Fred Alger Management, LLC Xenon Pharmaceuticals Inc. Transaction History

Fred Alger Management, LLC

  • $19.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$30.79 - $39.82 $1.39 Million - $1.8 Million
45,143 New
45,143 $1.63 Million
Q4 2021

Feb 14, 2022
SELL
$15.6 - $35.4 $1.65 Million - $3.75 Million
-105,989 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$14.86 - $19.45 $1.57 Million - $2.06 Million
105,989 New
105,989 $1.62 Million

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.39B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email